Preclinical News and Research

RSS
Helsinn commences Netupitant/Palonosetron Phase III combination study in CINV

Helsinn commences Netupitant/Palonosetron Phase III combination study in CINV

CoPlex, Hawthorn sign license agreement for hawAD14 Alzheimer's drug

CoPlex, Hawthorn sign license agreement for hawAD14 Alzheimer's drug

UCLA's gene-based imaging system can accurately detect metastatic prostate cancers

UCLA's gene-based imaging system can accurately detect metastatic prostate cancers

Ambrx, Bristol-Myers Squibb collaborate for novel biologics to treat heart failure and diabetes

Ambrx, Bristol-Myers Squibb collaborate for novel biologics to treat heart failure and diabetes

Adamis receives patents for APC-200 prostate cancer drug in South Africa, Singapore

Adamis receives patents for APC-200 prostate cancer drug in South Africa, Singapore

Preclinical data from two Pulmatrix's PUR118 study to be presented at ERS 2011

Preclinical data from two Pulmatrix's PUR118 study to be presented at ERS 2011

USPTO issues patent for Lixte's LB-100 to treat cancer

USPTO issues patent for Lixte's LB-100 to treat cancer

AGTC receives FFB grant to evaluate gene therapy treatment for X-linked Retinoschisis

AGTC receives FFB grant to evaluate gene therapy treatment for X-linked Retinoschisis

NIH-funded project to develop new class of tissue regeneration therapeutics

NIH-funded project to develop new class of tissue regeneration therapeutics

Positive data from InVivo's biomaterial scaffold implant preclinical study on acute SCI

Positive data from InVivo's biomaterial scaffold implant preclinical study on acute SCI

Silence Therapeutics reports revenue of £354,078 for six months ended 30 June 2011

Silence Therapeutics reports revenue of £354,078 for six months ended 30 June 2011

Niiki Pharma announces positive data from ongoing trial of novel anti-cancer agent NKP-1339

Niiki Pharma announces positive data from ongoing trial of novel anti-cancer agent NKP-1339

Nuevolution announces collaboration in drug discovery with Boehringer Ingelheim

Nuevolution announces collaboration in drug discovery with Boehringer Ingelheim

SK Biopharmaceuticals, Mayo Clinic collaborate to develop new treatments for ALS

SK Biopharmaceuticals, Mayo Clinic collaborate to develop new treatments for ALS

Calgary researchers discover new class of anti-inflammatory agents

Calgary researchers discover new class of anti-inflammatory agents

Powerful new antibiotic treatment for MRSA and C. difficile bugs

Powerful new antibiotic treatment for MRSA and C. difficile bugs

Mayo Clinic, SK biopharmaceuticals collaborate to discover new ALS drugs

Mayo Clinic, SK biopharmaceuticals collaborate to discover new ALS drugs

Positive data from NovaDigm's NDV-3 vaccine preclinical study on VVC

Positive data from NovaDigm's NDV-3 vaccine preclinical study on VVC

Preclinical studies shows EmPAC more effective than Taxol

Preclinical studies shows EmPAC more effective than Taxol

Positive Phase 1 data for NovaDigm NDV-3 vaccine presented at 51st ICAAC

Positive Phase 1 data for NovaDigm NDV-3 vaccine presented at 51st ICAAC

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.